Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 11
Submit an article Journal homepage
120
Views
18
CrossRef citations to date
0
Altmetric
Review

T-regulatory lymphocytes and chronic viral hepatitis

Simon M Rushbrook University of Cambridge School of Clinical Medicine, Department of Medicine, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK +44 0 1223 586614; +44 0 1223 216111; [email protected]
,
Matthew Hoare University of Cambridge School of Clinical Medicine, Department of Medicine, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK +44 0 1223 586614; +44 0 1223 216111; [email protected]
&
Graeme JM Alexander
Pages 1689-1703 | Published online: 26 Oct 2007

Bibliography

  • CHAN HL, SUNG JJ: Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. (2006) 26:153-161.
  • KANE M: Global programme for control of hepatitis B infection. Vaccine (1995) (13 Suppl.) 1:S47-S49.
  • LEE WM: Hepatitis B virus infection. N. Engl. J. Med. (1997) 337:1733-1745.
  • POYNARD T, YUEN MF, RATZIU V, LAI CL: Viral hepatitis C. Lancet (2003) 362:2095-2100.
  • FARCI P, ALTER HJ, GOVINDARAJAN S et al.: Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 258:135-140.
  • KATZE MG, HE Y, GALE M Jr: Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. (2002) 2:675-687.
  • CARRENO V, PARDO M, LOPEZ-ALCOROCHO JM, RODRIGUEZ-INIGO E, BARTOLOME J, CASTILLO I: Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. J. Infect. Dis. (2006) 194:53-60.
  • CARRENO V: Occult hepatitis C virus infection: a new form of hepatitis C. World J. Gastroenterol. (2006) 12:6922-6925.
  • BOWEN DG, WALKER CM: Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature (2005) 436:946-952.
  • LECHNER F, WONG DK, DUNBAR PR et al.: Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. (2000) 191:1499-1512.
  • FERRARI C, PENNA A, BERTOLETTI A et al.: Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. (1990) 145:3442-3449.
  • JUNG MC, SPENGLER U, SCHRAUT W et al.: Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. (1991) 13:310-317.
  • PENNA A, DEL PG, CAVALLI A et al.: Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology (1997) 25:1022-1027.
  • MAINI MK, BONI C, OGG GS et al.: Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 117:1386-1396.
  • FERRARI C, BERTOLETTI A, PENNA A et al.: Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. (1991) 88:214-222.
  • PENNA A, CHISARI FV, BERTOLETTI A et al.: Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. (1991) 174:1565-1570.
  • DIEPOLDER HM, JUNG MC, WIERENGA E et al.: Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J. Virol. (1996) 70:7540-7548.
  • PENNA A, ARTINI M, CAVALLI A et al.: Long-lasting memory T cell responses following self-limited acute hepatitis B. J. Clin. Invest. (1996) 98:1185-1194.
  • REHERMANN B, LAU D, HOOFNAGLE JH, CHISARI FV: Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. (1996) 97:1655-1665.
  • JUNG MC, SPENGLER U, SCHRAUT W et al.: Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. (1991) 13:310-317.
  • SUGIMOTO K, IKEDA F, STADANLICK J, NUNES FA, ALTER HJ, CHANG KM: Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology (2003) 38:1437-1448.
  • GERLACH JT, DIEPOLDER HM, JUNG MC et al.: Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology (1999) 117:933-941.
  • CACCIARELLI TV, MARTINEZ OM, GISH RG, VILLANUEVA JC, KRAMS SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon α. Hepatology (1996) 24:6-9.
  • TSAI SL, LIAW YF, CHEN MH, HUANG CY, KUO GC: Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology (1997) 25:449-458.
  • MILICH DR, JONES JE, HUGHES JL, PRICE J, RANEY AK, MCLACHLAN A: Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA (1990) 87:6599-6603.
  • MILICH DR, SCHODEL F, PETERSON DL, JONES JE, HUGHES JL: Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur. J. Immunol. (1995) 25:1663-1672.
  • MILICH DR, SCHODEL F, HUGHES JL, JONES JE, PETERSON DL: The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J. Virol. (1997) 71:2192-2201.
  • MILICH DR, CHEN MK, HUGHES JL, JONES JE: The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J. Immunol. (1998) 160:2013-2021.
  • WANG H, ECKELS DD: Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J. Immunol. (1999) 162:4177-4183.
  • GODKIN A, JEANGUET N, THURSZ M, OPENSHAW P, THOMAS H: Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur. J. Immunol. (2001) 31:1438-1446.
  • ROSEN HR, HINRICHS DJ, GRETCH DR et al.: Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology (1999) 117:926-932.
  • ARTINI M, NISINI R, MISSALE G et al.: Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes. Viral Immunol. (1995) 8:63-73.
  • FIORE G, ANGARANO I, CACCETTA L et al.: In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C. Eur. J. Gastroenterol. Hepatol. (1997) 9:491-496.
  • MINUTELLO MA, PILERI P, UNUTMAZ D et al.: Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. (1993) 178:17-25.
  • BARNES E, HARCOURT G, BROWN D, LUCAS M, PHILLIPS R, DUSHEIKO G, KLENERMAN P: The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology (2002) 36:743-754.
  • LOK AS: Chronic hepatitis B. N. Engl. J. Med. (2002) 346:1682-1683.
  • BONI C, BERTOLETTI A, PENNA A et al.: Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. (1998) 102:968-975.
  • MARINOS G, NAOUMOV NV, WILLIAMS R: Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Hepatology (1996) 24:991-995.
  • LECHNER F, WONG DK, DUNBAR PR et al.: Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. (2000) 191:1499-1512.
  • LECHNER F, WONG DK, DUNBAR PR et al.: Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. (2000) 191:1499-1512.
  • WEBSTER GJ, REIGNAT S, BROWN D et al.: Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. (2004) 78:5707-5719.
  • REIGNAT S, WEBSTER GJ, BROWN D et al.: Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. (2002) 195:1089-1101.
  • BONI C, PENNA A, BERTOLETTI A et al.: Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J. Hepatol. (2003) 39:595-605.
  • MAINI MK, BONI C, OGG GS et al.: Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 117:1386-1396.
  • WEBSTER GJ, REIGNAT S, MAINI MK et al.: Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 32:1117-1124.
  • MAINI MK, BONI C, LEE CK et al.: The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. (2000) 191:1269-1280.
  • APPAY V, DUNBAR PR, CALLAN M et al.: Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. (2002) 8:379-385.
  • LUCAS M, VARGAS-CUERO AL, LAUER GM et al.: Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J. Immunol. (2004) 172:1744-1753.
  • BARBER DL, WHERRY EJ, MASOPUST D et al.: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2006) 439:682-687.
  • DAY CL, KAUFMANN DE, KIEPIELA P et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 443:350-354.
  • PENNA A, PILLI M, ZERBINI A et al.: Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology (2007) 45:588-601.
  • BARBER DL, WHERRY EJ, MASOPUST D et al.: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2006) 439:682-687.
  • DAY CL, KAUFMANN DE, KIEPIELA P et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 443:350-354.
  • URBANI S, AMADEI B, TOLA D et al.: PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. (2006) 80:11398-11403.
  • RUSHBROOK SM, WARD SM, UNITT E et al.: Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J. Virol. (2005) 79:7852-7859.
  • NISHIZUKA Y, SAKAKURA T: Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science (1969) 166:753-755.
  • KOJIMA A, TANAKA-KOJIMA Y, SAKAKURA T, NISHIZUKA Y: Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab. Invest. (1976) 34:550-557.
  • KOJIMA A, TAGUCHI O, NISHIZUKA Y: Experimental production of possible autoimmune gastritis followed by macrocytic anemia in athymic nude mice. Lab. Invest. (1980) 42:387-395.
  • SAKAGUCHI S, TAKAHASHI T, NISHIZUKA Y: Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. (1982) 156:1577-1586.
  • SAKAGUCHI S, TAKAHASHI T, NISHIZUKA Y: Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J. Exp. Med. (1982) 156:1565-1576.
  • POWRIE F, LEACH MW, MAUZE S, MENON S, CADDLE LB, COFFMAN RL: Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity (1994) 1:553-562.
  • MORRISSEY PJ, CHARRIER K, BRADDY S, LIGGITT D, WATSON JD: CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med. (1993) 178:237-244.
  • POWRIE F, MASON D: OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med. (1990) 172:1701-1708.
  • SAKAGUCHI S, SAKAGUCHI N, ASANO M, ITOH M, TODA M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. (1995) 155:1151-1164.
  • ASANO M, TODA M, SAKAGUCHI N, SAKAGUCHI S: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. (1996) 184:387-396.
  • SURI-PAYER E, AMAR AZ, THORNTON AM, SHEVACH EM: CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. (1998) 160:1212-1218.
  • THORNTON AM, SHEVACH EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. (1998) 188:287-296.
  • NG WF, DUGGAN PJ, PONCHEL F et al.: Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood (2001) 98:2736-2744.
  • DIECKMANN D, PLOTTNER H, BERCHTOLD S, BERGER T, SCHULER G: Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. (2001) 193:1303-1310.
  • JONULEIT H, SCHMITT E, STASSEN M, TUETTENBERG A, KNOP J, ENK AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. (2001) 193:1285-1294.
  • TAAMS LS, SMITH J, RUSTIN MH, SALMON M, POULTER LW, AKBAR AN: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. (2001) 31:1122-1131.
  • LEVINGS MK, SANGREGORIO R, RONCAROLO MG: Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. (2001) 193:1295-1302.
  • SIMARK-MATTSSON C, DAHLGREN U, ROOS K: CD4+CD25+ T lymphocytes in human tonsils suppress the proliferation of CD4+. Scand. J. Immunol. (2002) 55:606-611.
  • ANNUNZIATO F, COSMI L, LIOTTA Fet al.: Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. (2002) 196:379-387.
  • STEPHENS LA, MOTTET C, MASON D, POWRIE F: Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. (2001) 31:1247-1254.
  • BAECHER-ALLAN C, BROWN JA, FREEMAN GJ, HAFLER DA: CD4+CD25 high regulatory cells in human peripheral blood. J. Immunol. (2001) 167:1245-1253.
  • TAAMS LS, VUKMANOVIC-STEJIC M, SMITH J et al.: Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur. J. Immunol. (2002) 32:1621-1630.
  • TAKAHASHI T, TAGAMI T, YAMAZAKI S et al.: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. (2000) 192:303-310.
  • GROUX H, O'GARRA A, BIGLER M et al.: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 389:737-742.
  • CEDERBOM L, HALL H, IVARS F: CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. (2000) 30:1538-1543.
  • MISRA N, BAYRY J, LACROIX-DESMAZES S, KAZATCHKINE MD, KAVERI SV: Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. (2004) 172:4676-4680.
  • READ S, MALMSTROM V, POWRIE F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. (2000) 192:295-302.
  • MANZOTTI CN, TIPPING H, PERRY LC, MEAD KI, BLAIR PJ, ZHENG Y, SANSOM DM: Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur. J. Immunol. (2002) 32:2888-2896.
  • DUTHOIT CT, MEKALA DJ, ALLI RS, GEIGER TL: Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes. J. Immunol. (2005) 174:155-163.
  • BELLINGHAUSEN I, KLOSTERMANN B, KNOP J, SALOGA J: Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J. Allergy Clin. Immunol. (2003) 111:862-868.
  • COSMI L, LIOTTA F, ANGELI R et al.: Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood (2004) 103:3117-3121.
  • DIECKMANN D, BRUETT CH, PLOETTNER H, LUTZ MB, SCHULER G: Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. (2002) 196:247-253.
  • JONULEIT H, SCHMITT E, KAKIRMAN H, STASSEN M, KNOP J, ENK AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. (2002) 196:255-260.
  • FONTENOT JD, GAVIN MA, RUDENSKY AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. (2003) 4:330-336.
  • HORI S, NOMURA T, SAKAGUCHI S: Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 299:1057-1061.
  • GAMBINERI E, TORGERSON TR, OCHS HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. (2003) 15:430-435.
  • BETTELLI E, DASTRANGE M, OUKKA M: Foxp3 interacts with nuclear factor of activated T cells and NF-{κ}B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA (2005) 102:5138-5143.
  • CHEN W, JIN W, HARDEGEN N et al.: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. (2003) 198:1875-1886.
  • MARIE JC, LETTERIO JJ, GAVIN M, RUDENSKY AY: TGF-{β}1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. (2005) 201:1061-1067.
  • FANTINI MC, BECKER C, MONTELEONE G, PALLONE F, GALLE PR, NEURATH MF: Cutting edge: TGF-β induces a regulatory phenotype in CD4+. J. Immunol. (2004) 172:5149-5153.
  • WALKER MR, KASPROWICZ DJ, GERSUK VHet al.: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J. Clin.Invest. (2003) 112:1437-1443.
  • MORGAN ME, VAN BILSEN JH, BAKKER AM et al.: Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. (2005) 66:13-20.
  • BRUDER D, PROBST-KEPPER M, WESTENDORF AM et al.: Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. (2004) 34:623-630.
  • CHRIST M, CARTNEY-FRANCIS NL, KULKARNI AB et al.: Immune dysregulation in TGF-β 1-deficient mice. J. Immunol. (1994) 153:1936-1946.
  • GREEN EA, GORELIK L, MCGREGOR CM, TRAN EH, FLAVELL RA: CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β-TGF-β receptor interactions in Type 1 diabetes. Proc. Natl. Acad. Sci. USA (2003) 100:10878-10883.
  • XU H, ZHANG GX, WYSOCKA M, WU CY, TRINCHIERI G, ROSTAMI A: The suppressive effect of TGF-β on IL-12-mediated immune modulation specific to a peptide Ac1-11 of myelin basic protein (MBP): a mechanism involved in inhibition of both IL-12 receptor β1 and β2. J. Neuroimmunol. (2000) 108:53-63.
  • URAUSHIHARA K, KANAI T, KO K et al.: Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene + regulatory T cells. J. Immunol. (2003) 171:708-716.
  • SEDDON B, MASON D: Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor β and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD. J. Exp. Med. (1999) 189:279-288.
  • BELGHITH M, BLUESTONE JA, BARRIOT S, MEGRET J, BACH JF, CHATENOUD L: TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. (2003) 9:1202-1208.
  • PICCIRILLO CA, LETTERIO JJ, THORNTON AM et al.: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. (2002) 196:237-246.
  • NAKAMURA K, KITANI A, STROBER W: Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. (2001) 194:629-644.
  • NAKAMURA K, KITANI A, FUSS I et al.: TGF-β1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol. (2004) 172:834-842.
  • CAMARA NO, SEBILLE F, LECHLER RI: Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur. J. Immunol. (2003) 33:3473-3483.
  • KURSAR M, BONHAGEN K, FENSTERLE J et al.: Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J. Exp. Med. (2002) 196:1585-1592.
  • COSMI L, LIOTTA F, LAZZERI E et al.: Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood (2003) 102:4107-4114.
  • AZUMA T, TAKAHASHI T, KUNISATO A, KITAMURA T, HIRAI H: Human CD4+CD25+ regulatory T cells suppress NKT cell functions. Cancer Res. (2003) 63:4516-4520.
  • KRIEGEL MA, LOHMANN T, GABLER C, BLANK N, KALDEN JR, LORENZ HM: Defective suppressor function of human CD4+CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. (2004) 199:1285-1291.
  • SHIMIZU J, YAMAZAKI S, SAKAGUCHI S: Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. (1999) 163:5211-5218.
  • GOLGHER D, JONES E, POWRIE F, ELLIOTT T, GALLIMORE A: Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. (2002) 32:3267-3275.
  • OKITA R, SAEKI T, TAKASHIMA S, YAMAGUCHI Y, TOGE T: CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer. Oncol. Rep. (2005) 14:1269-1273.
  • LI X, YE DF, XIE X, CHEN HZ, LU WG: Proportion of CD4+CD25+ regulatory T cell is increased in the patients with ovarian carcinoma. Cancer Invest. (2005) 23:399-403.
  • UNITT E, RUSHBROOK SM, MARSHALL A et al.: Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology (2005) 41:722-730.
  • YANG XH, YAMAGIWA S, ICHIDA T et al.: Increase of CD4+CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J. Hepatol. (2006) 45:254-262.
  • PETERSEN RP, CAMPA MJ, SPERLAZZA J et al.: Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer (2006) 107:2866-2872.
  • BELKAID Y, PICCIRILLO CA, MENDEZ S, SHEVACH EM, SACKS DL: CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature (2002) 420:502-507.
  • AANDAHL EM, MICHAELSSON J, MORETTO WJ, HECHT FM, NIXON DF: Human CD4+CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. (2004) 78:2454-2459.
  • HISAEDA H, MAEKAWA Y, IWAKAWA D et al.: Escape of malaria parasites from host immunity requires CD4+CD25+ regulatory T cells. Nat. Med. (2004) 10:29-30.
  • MONNERET G, DEBARD AL, VENET F et al.: Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. (2003) 31:2068-2071.
  • STOOP JN, VAN DER MOLEN RG, BAAN CC et al.: Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology (2005) 41:771-778.
  • XU D, FU J, JIN L et al.: Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. (2006) 177:739-747.
  • CABRERA R, TU Z, XU Y et al.: An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology (2004) 40:1062-1071.
  • FU JL, XU DP, SHI M et al.: The phenotype and function of CD4+CD25+ regulatory T cells in hepatitis B patients. Zhonghua Nei Ke Za Zhi (2006) 45:642-645.
  • STOOP JN, VAN DER MOLEN RG, BAAN CC et al.: Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology (2005) 41:771-778.
  • FRANZESE O, KENNEDY PT, GEHRING AJ et al.: Modulation of the CD8+-T-cell response by CD4+CD25+ regulatory T cells in patients with hepatitis B virus infection. J. Virol. (2005) 79:3322-3328.
  • YANG G, LIU A, XIE Q et al.: Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int. Immunol. (2007) 19:133-140.
  • BOLACCHI F, SINISTRO A, CIAPRINI C et al.: Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin. Exp. Immunol. (2006) 144:188-196.
  • LONGHI MS, MA Y, BOGDANOS DP, CHEESEMAN P, MIELI-VERGANI G, VERGANI D: Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J. Hepatol. (2004) 41:31-37.
  • LAN RY, CHENG C, LIAN ZX et al.: Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (2006) 43:729-737.
  • WARD SM, FOX BC, BROWN PJ et al.: QUANTIFICATION and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J. Hepatol. (2007):(In Press).
  • BOETTLER T, SPANGENBERG HC, NEUMANN-HAEFELIN C et al.: T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J. Virol. (2005) 79:7860-7867.
  • LUCAS M, VARGAS-CUERO AL, LAUER GM et al.: Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J. Immunol. (2004) 172:1744-1753.
  • ABEL M, SENE D, POL S et al.: Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology (2006) 44:1607-1616.
  • NISII C, TEMPESTILLI M, AGRATI C et al.: Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection. J. Hepatol. (2006) 44:475-483.
  • KONDO Y, KOBAYASHI K, UENO Y et al.: Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J. Gastroenterol. (2006) 12:4310-4317.
  • FU J, XU D, LIU Z et al.: Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology (2007) 132:2328-2339.
  • LOK AS: Chronic hepatitis B. N. Engl. J. Med. (2002) 346:1682-1683.
  • ALEXANDER GJ, BRAHM J, FAGAN EA et al.: Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet (1987) 2:66-69.
  • HOOFNAGLE JH, SEEFF LB: Peginterferon and ribavirin for chronic hepatitis C. N. Engl. J. Med. (2006) 355:2444-2451.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.